{
  "ticker": "EOS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962003",
  "id": "02962003",
  "pages": 4,
  "price_sensitive": false,
  "date": "20250625",
  "time": "1613",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250625/pdf/06l36vvcg77k4m.pdf",
  "summary": "**Summary of ASX Announcement**  \n\n- **Late Disclosure Explanation**:  \n  - Appendix 3Y for Dr Andreas Schwer (CEO) was lodged late (20 June 2025 vs. deadline of 18 June 2025) due to an administrative oversight.  \n  - Change related to 70,354 deferred shares granted to Dr Schwer post-AGM approval (allotted 11 June 2025).  \n\n- **Compliance Assurance**:  \n  - EOS asserts existing director disclosure arrangements under Listing Rule 3.19B are adequate; attributes lapse to isolated oversight.  \n  - No material impact on valuation, liquidity, or capital structure identified.  \n\n**Classification**: Regulatory response (no material trading or capital markets impact).  \n\n**Conclusion**: No material information for trading or capital markets decisions.",
  "usage": {
    "prompt_tokens": 1992,
    "completion_tokens": 168,
    "total_tokens": 2160,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-25T06:20:00.503766"
}